Repurposing metformin: Can it revolutionize oral cancer treatment as a neoadjuvant therapeutic agent?
Saved in:
Main Authors: | Deepavalli Arumuganainar, Saravanan Sekaran |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-09-01
|
Series: | Oral Oncology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024004217 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Green tea epigallocatechin-3-gallate (EGCG): A promising therapeutic agent for oral cancer
by: Saravanan Sekaran, et al.
Published: (2024-03-01) -
Repurposing Amlexanox to treat head and neck cancers: Increasing neoantigen expression to facilitate immunotherapy
by: Saravanan Sekaran, et al.
Published: (2024-06-01) -
Increasing the neoantigen expression by nonsense mediated mRNA decay inhibitors: An effective therapeutic approach in oral cancer?
by: Saravanan Sekaran
Published: (2024-06-01) -
Biotechnology breakthroughs: Revolutionizing oral cancer treatment
by: Safin Hussein, et al.
Published: (2024-06-01) -
Exploring FBXO43 as a potential therapeutic target: Implications for oral cancer progression
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01)